AcariaHealth Sparks Innovation at 2025 Healthcare Advocate Summit with Hackathon and Expert Panels
Rhea-AI Summary
AcariaHealth, a specialty pharmacy solutions provider and Centene Corporation (NYSE: CNC) subsidiary, will host multiple sessions at the 2025 Healthcare Advocate Summit in Las Vegas from September 2-5, 2025.
The company will lead a pioneering "Reimagine Access" Hackathon featuring themed breakout discussions on healthcare access challenges, including biosimilars, home infusion, and Medicare/Medicaid access. Additionally, AcariaHealth will present an expert panel on biosimilars and market disruption, and a roundtable discussion on the Medicare Prescription Payment Plan (M3P).
Led by CEO Jessica Ciccolella-Kahl, these sessions demonstrate AcariaHealth's commitment to improving healthcare access through innovation and advocacy in specialty pharmacy services.
Positive
- None.
Negative
- None.
News Market Reaction – CNC
On the day this news was published, CNC declined 1.44%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Reimagine Access: A Hackathon for Healthcare Advocates
Tuesday, Sept. 2 | 1:00–3:30 PM PT | Florentine 1–11
This dynamic, hands-on session brings together healthcare advocates, providers, and pharmacy professionals for fast-paced, themed breakout discussions focused on real-world access challenges:
- Breaking Bio – Biosimilars & Continuity of Care
- No Place Like Home – Reimagining Home Infusion
- Coverage Unlocked – Medicare/Medicaid Access
- The Access Avengers – SP + Advocate Partnerships
- Pharmaformers – Transforming Specialty Pharmacy
Guided by AcariaHealth Regional Sales Directors, each table invites participants to brainstorm actionable solutions they can take back to their organizations.
Expert Panel: Biosimilars & Market Disruption
Thursday, Sept. 4 | 1:30–2:20 PM PT
Join AcariaHealth leaders as they break down biosimilar trends, payer mandates, and how to prevent care disruption. Featuring a new video spotlighting our Provider Experience Managers (PEMs) and their impact on provider-pharmacy collaboration.
Panelists:
- Alysha Robinson, PharmD, CSP – Director, Specialty Pharmacy Program Management
- Kathleen Stenberg, PharmD, CSP – Lead Specialty Pharmacist, Operational Excellence
- Robin Waida – Director, Physician Sales
- Gil Rosas, BSN – Account Executive
Can't attend? Register for our October Biosimilars Webinar.
Roundtable: M3P Unpacked – Your Final Questions, Clarified
Friday, Sept. 5 | 8:30–9:30 AM PT | Pompeian 1–11
Speaker: Sheri Wallace - Account Executive
Wrap up the Summit with this interactive discussion on the Medicare Prescription Payment Plan (M3P) and its implications for patients and advocates. No slides—just your questions answered.
Advancing Access, Together
"At AcariaHealth, we believe access to care should be as seamless as the care itself," said Jessica Ciccolella-Kahl, CEO of AcariaHealth. "We're proud to lead these conversations and help drive lasting solutions."
From biosimilar transitions to breakthrough collaborations, AcariaHealth is committed to reshaping specialty pharmacy through innovation, advocacy, and compassion.
Heading to the Healthcare Advocate Summit? Stop by our sessions, meet the team, and follow us on LinkedIn for live updates.
About AcariaHealth
AcariaHealth is a national specialty pharmacy dedicated to supporting patients with complex conditions through personalized care and clinical expertise. As a Centene company, AcariaHealth leverages the strength of the largest Medicaid managed care organization to deliver transformative outcomes across the country.
Learn more: AcariaHealth.com
Follow us on LinkedIn
View original content to download multimedia:https://www.prnewswire.com/news-releases/acariahealth-sparks-innovation-at-2025-healthcare-advocate-summit-with-hackathon-and-expert-panels-302538826.html
SOURCE AcariaHealth
FAQ
When and where is AcariaHealth presenting at the 2025 Healthcare Advocate Summit?
What is the 'Reimagine Access' Hackathon by AcariaHealth (NYSE: CNC)?
Who are the speakers for AcariaHealth's biosimilar panel at the 2025 Healthcare Summit?
What topics will AcariaHealth cover in their M3P roundtable discussion?